Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PRINCETON, N.J., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced that it intends to request a hearing before a NASDAQ Listing Qualifications Panel ("Panel") to present a...
-
PRINCETON, N.J., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced results for the quarter ended September 30, 2008. Recent company developments have included the...
-
PRINCETON, N.J., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small...
-
PRINCETON, N.J., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small...
-
PRINCETON, N.J., Oct. 3, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced it received a notice...
-
Acquisition Would Result in Well Capitalized Company With Robust Royalty Assets and Broad Research Pipeline Conference Call Today at 5:30p.m. Eastern SAN...
-
PRINCETON, N.J., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has...
-
PRINCETON, N.J., Aug. 5, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, has implemented the restructuring...
-
PRINCETON, N.J., July 31, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP) today announced results for the quarter ended June 30, 2008 and further plans related to the clinical development of...
-
PRINCETON, N.J., July 30, 2008 (PRIME NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Brian M. Posner,...